Pancreatic Cancer: Screening and Early Detection

Gastroenterol Clin North Am. 2025 Mar;54(1):205-221. doi: 10.1016/j.gtc.2024.09.006. Epub 2024 Nov 7.

Abstract

Pancreatic cancer, often diagnosed at advanced stages, has poor survival rates. Effective screening aims to detect the disease early, improving outcomes. Current guidelines recommend screening high-risk groups, including those with a family history or genetic predispositions, using methods like endoscopic ultrasound and MRI. The American Gastroenterological Association and other organizations advise annual surveillance for high-risk individuals, typically starting at the age of 50 or 10 years younger than the youngest affected relative. For certain genetic syndromes, such as Peutz-Jeghers syndrome or hereditary pancreatitis, screening may begin as early as the age of 35 to 40 years.

Keywords: Cancer genetic syndromes; High-risk groups; Pancreatic adenocarcinoma; Pancreatic cancer; Screening and surveillance.

Publication types

  • Review

MeSH terms

  • Early Detection of Cancer* / methods
  • Endosonography
  • Humans
  • Magnetic Resonance Imaging
  • Mass Screening / methods
  • Pancreatic Neoplasms* / diagnosis
  • Pancreatic Neoplasms* / genetics